CP
GILD icon

CenterBook Partners’s Gilead Sciences GILD Stock Holding History

CenterBook Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,940
Closed -$852K – 693
2025
Q4 		$852K Buy
+6,940
New +$843K 0.04% 399
2023
Q4 		– Sell
-9,495
Closed -$712K – 428
2023
Q3 		$712K Buy
+9,495
New +$730K 0.09% 288

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CenterBook Partners's GILD Position: Q1 2026 in Review

CenterBook Partners sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 6,940 shares — an estimated $852K sold.

CenterBook Partners first reported a position in GILD in Q3 2023 and held it in 2 quarters. The position peaked at $852K in Q4 2025. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • CenterBook Partners reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • CenterBook Partners sold 6,940 Gilead Sciences shares in Q1 2026, an estimated $852K.
  • CenterBook Partners first reported a position in Gilead Sciences in Q3 2023 and held it in 2 quarters.
  • CenterBook Partners's Gilead Sciences position peaked at $852K in Q4 2025.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on CenterBook Partners's 13F filing for Q1 2026, filed 5 May 2026.